T Cell Dysfunction and Survival in ALS Mice
Author Information
Author(s): Rebecca Banerjee, R. Lee Mosley, Ashley D. Reynolds, Alok Dhar, Vernice Jackson-Lewis, Paul H. Gordon, Serge Przedborski, Howard E. Gendelman
Primary Institution: University of Nebraska Medical Center
Hypothesis
The study investigates the role of T cell immunity in the progression of amyotrophic lateral sclerosis (ALS) in G93A-SOD1 transgenic mice and its implications for human ALS.
Conclusion
The study found that T cell dysfunction is linked to a progressive immunodeficiency in G93A-SOD1 mice, which affects their survival and neurological function.
Supporting Evidence
- T cell immune function was significantly impaired in G93A-SOD1 Tg mice by 19 weeks of age.
- Weekly COP-1 immunization increased the mean age of survival in female G93A-SOD1 Tg mice.
- Adoptive transfer of activated Treg or Teff cells improved neurological function and extended survival in G93A-SOD1 Tg mice.
- Human ALS patients exhibited a decrease in naïve T cells and an increase in memory T cells compared to age-matched controls.
Takeaway
Researchers studied mice with ALS and found that their immune system didn't work well, which made the disease worse. They think fixing the immune system could help treat ALS.
Methodology
The study involved immunizing G93A-SOD1 mice with COP-1 and analyzing T cell function, survival rates, and immune responses through various assays.
Potential Biases
Potential bias in interpreting results due to the reliance on a single animal model for ALS.
Limitations
The study primarily focused on a specific mouse model, which may not fully represent human ALS pathology.
Participant Demographics
The study included G93A-SOD1 transgenic mice and human ALS patients, with comparisons made to age-matched controls.
Statistical Information
P-Value
p=0.0413
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website